ArticleJournal of cellular and molecular medicine2017

A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.

Yiming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.